Table 1 Definitions of Malaria Chemoprevention Strategies*
From: Malaria chemoprevention and drug resistance: a review of the literature and policy implications
Intermittent preventive treatment in pregnancy (IPTp) | A full therapeutic course of anti-malarial medicine given to pregnant women at routine prenatal visits, regardless of whether the woman is infected with malaria |
Intermittent preventive treatment in infants (IPTi) | A full therapeutic course of sulfadoxine-pyrimethamine delivered to infants in co-administration with DTP2/Penta2, DTP3/Penta3 and measles immunization, regardless of whether the infant is infected with malaria |
Seasonal malaria chemoprevention (SMC) | Intermittent administration of full treatment courses of an anti-malarial medicine during the malaria season to prevent malarial illness. The objective is to maintain therapeutic concentrations of an anti-malarial drug in the blood throughout the period of greatest risk for malaria |
Note: This intervention is recommended only for areas with highly seasonal malaria, where transmission occurs during a few months of the year | |
Mass drug administration (MDA) | Administration of anti-malarial treatment to all age groups of a defined population or every person living in a defined geographical area (except those for whom the medicine is contraindicated) at approximately the same time and often at repeated intervals |